{
  "schemaVersion": "deck-intelligence.v1",
  "id": "019de075-814d-76ed-b6e6-6e437a6b6631",
  "slug": "56480dbdf83cce5ae4f2fad948f0ee58",
  "title": "Dare Bioscience | Investor Presentation Deck | 26 slides",
  "subtitle": "Daré Bioscience · 2023-08",
  "author": "Daré Bioscience",
  "date": "2023-08-01 00:00:00",
  "pageCount": 26,
  "kind": "pitchdeck",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "document": {
    "id": "019de075-814d-76ed-b6e6-6e437a6b6631",
    "slug": "56480dbdf83cce5ae4f2fad948f0ee58",
    "title": "Dare Bioscience | Investor Presentation Deck | 26 slides",
    "rawTitle": "Dare Bioscience | Investor Presentation Deck | 26 slides",
    "authorId": "dare-bioscience",
    "authorName": "Daré Bioscience",
    "authorDisplay": "Daré Bioscience",
    "kind": {
      "slug": "pitchdeck",
      "label": "Pitch deck"
    },
    "sourceType": {
      "slug": "investor_relations",
      "label": "Investor relations"
    },
    "fileName": "2023-08__dare-bioscience__investor-pres__56480dbd.pdf",
    "sourceUrl": "https://www.slidebook.io/company/dare-bioscience/presentation/56480dbdf83cce5ae4f2fad948f0ee58/",
    "sourceDate": "2023-10-08 00:00:00",
    "presentationDate": "2023-08-01 00:00:00",
    "ingestedAt": "2026-04-30 22:14:50.546198+00",
    "status": "ready",
    "pageCount": 26,
    "orientation": "landscape",
    "aspectRatio": 1.7777778,
    "targetCompany": null,
    "targetTicker": null,
    "metadata": {
      "corpus": "slidebook",
      "industry": "biotechnology",
      "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2023-08__dare-bioscience__investor-pres__56480dbd",
      "image_width": 1920,
      "image_format": "jpg",
      "deck_type_raw": "Investor Presentation Deck",
      "deck_type_slug": null,
      "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/"
    }
  },
  "coverage": {
    "pageCount": 26,
    "pagesIndexed": 26,
    "pagesWithImages": 26,
    "pagesWithMetadata": 26,
    "imageCoveragePct": 100,
    "metadataCoveragePct": 100,
    "componentCount": 124,
    "chartCount": 3,
    "metricSlides": 0,
    "toolMatches": 6,
    "documentToolMatches": 0,
    "frameworkMatches": 5,
    "arcMatches": 1,
    "beatMatches": 3,
    "loopMatches": 1,
    "patternMatches": 0,
    "storymakersMatch": false,
    "scoreAvailable": false,
    "reviewAvailable": false,
    "activistThesisAvailable": false,
    "pitchdeckMetadataAvailable": false,
    "pitchdeckProfileAvailable": false
  },
  "blocks": [],
  "matches": {
    "arcs": [
      {
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "matchId": "0b2578b2-1add-4a04-bc3d-ab9bef32079b",
        "evidence": "The deck follows a structure similar to the Sequoia Pitch, with a clear problem statement, solution, and business model",
        "isPrimary": true,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-16 22:36:02.466711+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "beats": [
      {
        "to": 8,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 8,
        "name": "Problem",
        "beatId": "7d9cc53d-18a2-4032-9a7e-ce50d00a7876",
        "matchId": "0b2578b2-1add-4a04-bc3d-ab9bef32079b",
        "beatType": {
          "name": "Problem",
          "slug": "sequoia-pitch-problem",
          "status": "active",
          "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
          "version": 1,
          "description": null
        },
        "evidence": "The deck presents a clear problem statement on page 8",
        "position": 0,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Complication",
          "slug": "complication",
          "status": "active",
          "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
          "version": 1,
          "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 9,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 7,
        "name": "Solution",
        "beatId": "188fa255-ca44-4d79-b6ab-0aff1c2bb57b",
        "matchId": "0b2578b2-1add-4a04-bc3d-ab9bef32079b",
        "beatType": {
          "name": "Solution",
          "slug": "sequoia-pitch-solution",
          "status": "active",
          "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
          "version": 1,
          "description": null
        },
        "evidence": "The deck presents solutions, including Sildenafil Cream, 3.6%, on pages 7-9",
        "position": 1,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Turn",
          "slug": "turn",
          "status": "active",
          "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
          "version": 1,
          "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 13,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 13,
        "name": "Market Size",
        "beatId": "663a8ca0-0fa2-4b77-883d-caaa97effcc5",
        "matchId": "0b2578b2-1add-4a04-bc3d-ab9bef32079b",
        "beatType": {
          "name": "Market Size",
          "slug": "sequoia-pitch-market-size",
          "status": "active",
          "canonId": "019dd9b8-20e6-729c-bc28-05442906d032",
          "version": 1,
          "description": null
        },
        "evidence": "The deck presents market sizing information on page 13",
        "position": 2,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Evidence",
          "slug": "evidence",
          "status": "active",
          "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
          "version": 1,
          "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      }
    ],
    "loops": [
      {
        "to": 11,
        "from": 8,
        "loop": {
          "name": "27_cost_of_inaction",
          "slug": "27-cost-of-inaction",
          "status": "active",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "description": "Quantify what happens if the audience does nothing",
          "familyLabel": null,
          "categoryName": "Urgency",
          "categorySlug": "urgency"
        },
        "matchId": "83faa245-7d21-49f3-aa4d-68f21da0e116",
        "evidence": "The deck presents the consequences of not addressing FSAD/FSIAD on pages 8-11",
        "position": 0,
        "objective": "Highlight the need for a treatment for FSAD/FSIAD",
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-16 22:36:02.645468+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "tools": [
      {
        "tool": {
          "name": "Emotional Appeal",
          "slug": "emotional-appeal",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-bde9-7668-8be7-0097678fec59",
          "version": 1,
          "bodyDocId": null,
          "description": "Connecting to audience feelings rather than just logic",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "134a6475-34ae-4b94-ade6-be70b0387686",
        "evidence": "paragraph/paragraph: At Daré Bioscience, women's health is Our Sole Focus. Innovation in women's health needs to be a priority. We are working hard to identify and advance new therapies that provide additional choices an",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-17 00:28:57.416927+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 1,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Deploy / Reshape / Invent (BCG)",
          "slug": "bcg-deploy-reshape-invent",
          "status": "active",
          "bestFor": null,
          "canonId": "019de52d-2044-72cc-b402-2511b4663d84",
          "version": 1,
          "bodyDocId": null,
          "description": null,
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "00cc175b-337d-4cd1-90a5-c0a5b5a3f78f",
        "evidence": "Clinical development timeline for XACIATO, Ovaprene, Sildenafil Cream, DARE-HRT1, and DARE-VVA1",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:58:22.063696+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 5,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Gantt chart",
          "slug": "gantt-chart",
          "status": "active",
          "bestFor": null,
          "canonId": "019de52d-1fa2-7206-bb14-bb9ff5fccdba",
          "version": 1,
          "bodyDocId": null,
          "description": null,
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "2fea0c07-4efe-4339-a5fd-67f99760a335",
        "evidence": "Pipeline development status table",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 03:58:22.14795+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 6,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Problem Statement Canvas",
          "slug": "problem-statement-canvas",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18",
          "version": 1,
          "bodyDocId": null,
          "description": "Structured definition of the problem: What? Who? Where? When? Scale?",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Architect",
        "layer": "slide",
        "agents": [
          "Architect"
        ],
        "matchId": "63ce8606-bbcb-4aef-8e39-ce555aadd0c0",
        "evidence": "Female Sexual Arousal Disorder (FSAD) is characterized primarily by inability to attain or maintain sufficient genital arousal during sexual activity",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:58:22.270656+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 8,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Social Proof",
          "slug": "social-proof",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-990d-7620-82b3-6dd286f34568",
          "version": 1,
          "bodyDocId": null,
          "description": "People adapt behavior based on what others do - show adoption and testimonials",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "d416ae37-87f8-4f57-8201-f99b8579bad0",
        "evidence": "image/logo: NIH Cooperative Research and Development Agreement (CRADA) for the Pivotal Phase 3 Study",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:28:52.362753+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 15,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Table data",
          "slug": "table-data",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
          "version": 1,
          "bodyDocId": null,
          "description": "Tabular layouts of structured data.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "480e03ed-613f-42a3-a16a-e09087f2af96",
        "evidence": "table/data: Baseline PCT's: 27.21, 23.20, 17.88, 24.80. Ovaprene PCT's: 0.48, 0.00, 1.18, 0.10.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 00:28:52.440546+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 16,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      }
    ],
    "frameworks": [
      {
        "matchId": "8b62473b-abda-4b4f-83b9-28baefd09957",
        "evidence": "Visual timeline mapping project phases over time",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 11:39:59.209+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 5,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "bff9020a-4a38-4e34-9728-123119d26a34",
        "evidence": "Visual representation of project phases over time",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 11:39:57.947+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 6,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "ef04e9f6-209c-4a71-bc43-746e83186b8a",
        "evidence": "Comparison of FSAD/FSIAD to erectile dysfunction (ED) in men.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:39:59.271+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 8,
        "frameworkName": "argument-from-analogy"
      },
      {
        "matchId": "7c2464fc-2a95-4055-90ca-cad2b681cc1d",
        "evidence": "Quantifies total addressable population and benchmarks against competitor revenue.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:39:58.542+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 13,
        "frameworkName": "market-sizing"
      },
      {
        "matchId": "98c39a80-f9a3-49c4-852f-ec026beb4970",
        "evidence": "Comparing existing contraceptive methods against a new proposed solution on a spectrum of effectiveness.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:39:58.783+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 14,
        "frameworkName": "comparison_frame"
      }
    ],
    "patterns": []
  },
  "storymakers": null,
  "score": null,
  "review": null,
  "activistThesis": null,
  "pitchdeck": {
    "metadata": null,
    "profile": null
  },
  "slides": [
    {
      "page": 1,
      "type": "setup",
      "title": "The slide uses a linguistic play on the company name to establish brand identity.",
      "function": "inspire_vision",
      "imagePath": "https://imgproxy.kitesheet.com/oivhNe_SBe6zWV4PWYcpKsbA0ZChs1Oy8_BkFIOGJcE/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81NjQ4MGRiZGY4M2NjZTVhZTRmMmZhZDk0OGYwZWU1OC9wMDAxLmpwZw",
      "rawType": "mission",
      "block": null,
      "metadata": {
        "slideType": "mission",
        "slideTypeCanon": {
          "name": "Mission",
          "slug": "mission",
          "status": "active",
          "canonId": "019de52d-0fce-7496-b34c-18fd6a6e3310",
          "version": 1,
          "description": null
        },
        "function": "inspire_vision",
        "functionCanon": {
          "name": "Inspire vision",
          "slug": "inspire_vision",
          "status": "active",
          "canonId": "019de52d-16d0-7756-83de-376eeac6fa40",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 45,
        "componentCount": 5,
        "textChars": 360,
        "nDataPoints": 0,
        "notes": "The slide uses a linguistic play on the company name to establish brand identity.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:57.276+00",
          "seconds": 2.951,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/1",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-1",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.3,
            "x": 0.559,
            "y": 0.12
          },
          "kind": "callout",
          "text": "DARÉ\nIN ITALIAN, IT MEANS \"TO GIVE.\"\nIN ENGLISH, IT MEANS \"TO BE BOLD.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.276+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fabaefef-2298-4a94-bff9-d0744f288900",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.495,
            "w": 0.455,
            "x": 0,
            "y": 0
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.276+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "15400706-0f93-4bb4-96f6-97b80c5d0ae6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.378,
            "w": 0.548,
            "x": 0,
            "y": 0.53
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.276+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4b9df549-9457-49fe-84ac-27238b33e895",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.125,
            "w": 0.465,
            "x": 0.469,
            "y": 0.455
          },
          "kind": "paragraph",
          "text": "At Daré Bioscience, women's health is Our Sole Focus. Innovation in women's health needs to be a priority. We are working hard to identify and advance new therapies that provide additional choices and improve outcomes so that we can make a difference in the lives of women everywhere.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.276+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "28696dcb-e32b-484d-a3dc-3f1cb84e88ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.045,
            "w": 0.155,
            "x": 0.469,
            "y": 0.345
          },
          "kind": "title",
          "text": "Women",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.276+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3b5bcbb5-8bfd-4c67-b4f0-17b8b9311e4b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Emotional Appeal",
            "slug": "emotional-appeal",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-bde9-7668-8be7-0097678fec59",
            "version": 1,
            "bodyDocId": null,
            "description": "Connecting to audience feelings rather than just logic",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "134a6475-34ae-4b94-ade6-be70b0387686",
          "evidence": "paragraph/paragraph: At Daré Bioscience, women's health is Our Sole Focus. Innovation in women's health needs to be a priority. We are working hard to identify and advance new therapies that provide additional choices an",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-17 00:28:57.416927+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 1,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "thumbSrc": "https://imgproxy.kitesheet.com/QhJRpASBq5RfkQZpEMvmWzZXSDUzAyM5VJkSIdXady4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81NjQ4MGRiZGY4M2NjZTVhZTRmMmZhZDk0OGYwZWU1OC9wMDAxLmpwZw",
      "imagePathAlt": "https://imgproxy.kitesheet.com/nIKp9cCrwn_sUqSlHkbtoPm6_7jm7mUitylctfPfYVA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81NjQ4MGRiZGY4M2NjZTVhZTRmMmZhZDk0OGYwZWU1OC9wMDAxLnBuZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/FeNfSEwK50jUfPONkCOE7qFFFUIdGFSXkUNQQQNcRlY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81NjQ4MGRiZGY4M2NjZTVhZTRmMmZhZDk0OGYwZWU1OC9wMDAxLnBuZw"
    },
    {
      "page": 2,
      "type": "setup",
      "title": "Dense legal text page typical of investor decks; Dare Bio logo top-left, page number '2' bottom-right.",
      "function": "front_matter",
      "rawType": "disclaimer",
      "block": null,
      "metadata": {
        "slideType": "disclaimer",
        "slideTypeCanon": {
          "name": "Disclaimer",
          "slug": "disclaimer",
          "status": "active",
          "canonId": "019de52d-0801-727b-b98a-5ed095aeee78",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 40,
        "componentCount": 4,
        "textChars": 433,
        "nDataPoints": 0,
        "notes": "Dense legal text page typical of investor decks; Dare Bio logo top-left, page number '2' bottom-right.",
        "elementsJson": null,
        "confidence": 0.95,
        "extraction": {
          "model": "claude-cli",
          "runId": null,
          "at": "2026-05-02 22:02:04.599+00",
          "seconds": null,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/2",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-2",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.78,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "disclaimer",
          "text": "This presentation is for informational purposes only and is not an offer to sell or a solicitation of an offer to buy any securities of Daré Bioscience, Inc. Includes forward-looking statements regarding XACIATO and product candidates, clinical trial advancement, regulatory approval, commercialization, and financing transactions. Refers to Risk Factors in Form 10-K and 10-Q filings.",
          "attrs": {
            "paragraphs": 4
          },
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 22:02:04.599+00",
            "model": "claude-cli",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9fc3ecce-a1fe-42d6-8347-7ebccb325598",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.07,
            "x": 0.02,
            "y": 0.02
          },
          "kind": "image",
          "text": "daré bio",
          "attrs": {
            "position": "top-left"
          },
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 22:02:04.599+00",
            "model": "claude-cli",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "590bf484-5e3b-4630-9bb0-90d85a74520d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.03,
            "x": 0.95,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "2",
          "attrs": {
            "role": "page-number"
          },
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 22:02:04.599+00",
            "model": "claude-cli",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "59f12257-bf34-4473-b88f-59342dacc1e5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.7,
            "x": 0.08,
            "y": 0.03
          },
          "kind": "title",
          "text": "Forward-Looking Statements; Disclaimers",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 22:02:04.599+00",
            "model": "claude-cli",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b64b049e-3a41-480a-8684-7fc858729c75",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 3,
      "type": "setup",
      "title": "The slide uses a two-column layout to contrast company strengths with market opportunity.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 8,
        "textChars": 981,
        "nDataPoints": 5,
        "notes": "The slide uses a two-column layout to contrast company strengths with market opportunity.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.437+00",
          "seconds": 3.669,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/3",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-3",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.46,
            "x": 0.47,
            "y": 0.6
          },
          "kind": "callout",
          "text": "Potential to Achieve Disproportional Return on Investment",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.437+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "000b31de-fc92-4e9f-af3e-8b3f53f3140c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.46,
            "x": 0.47,
            "y": 0.19
          },
          "kind": "callout",
          "text": "Underserved Market in Need of Innovation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.437+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5090d569-94d5-43f2-b348-5c40c1b5a845",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.38,
            "x": 0.07,
            "y": 0.19
          },
          "kind": "callout",
          "text": "Value Drivers & Competitive Advantages",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.437+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "986aecff-30fc-4a5b-bede-94ef817e894a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.4,
            "x": 0.07,
            "y": 0.27
          },
          "kind": "list",
          "text": "Meaningful market potential for differentiated products\nDiverse pipeline with independent outcomes\n505(b)(2) FDA pathway planned for most candidates\nMultiple novel delivery platforms\nCommercial value in women's health",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.437+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e9c11f62-20a0-4923-9a8d-226ba869b458",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.46,
            "x": 0.47,
            "y": 0.27
          },
          "kind": "paragraph",
          "text": "Approximately 1% of healthcare research is invested in female-specific conditions beyond oncology.\nWomen's health conditions outside of oncology comprise less than 2% of the current healthcare pipeline.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.437+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4f44c9be-18e2-49d3-97c5-667ac431f319",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.46,
            "x": 0.47,
            "y": 0.68
          },
          "kind": "paragraph",
          "text": "Women's health products make up 27% of total blockbuster products while contributing to 35% of total blockbuster sales.\nWomen control 80% of U.S. healthcare purchasing decisions.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.437+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f13599f2-eff2-4e2d-ba4f-fd0115b87633",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.6,
            "x": 0.02,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "1- McKinsey & Company, February 14, 2022, Unlocking Opportunities in Women's Healthcare\n2- GlobalData Drugs Database and McKinsey & Company\n3- IQVIA Monthly Global MIDAS $ Const-Exchng (MNF) 2013-2022",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.437+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e0e1e7bf-4cc0-4510-8ae9-7331eacca551",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.7,
            "x": 0.07,
            "y": 0.04
          },
          "kind": "title",
          "text": "Daré Bioscience: Women's Health is our Sole Focus",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.437+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d146d14-a0e8-4ecf-9575-b580575f42ac",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 4,
      "type": "appendix",
      "title": "The slide uses a structured list format to categorize assets under Contraception, Vaginal Health, Reproductive Health/Menopause/Sexual Health, and Fertility.",
      "function": "present_solution",
      "rawType": "other",
      "block": null,
      "metadata": {
        "slideType": "other",
        "slideTypeCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 6,
        "textChars": 447,
        "nDataPoints": 0,
        "notes": "The slide uses a structured list format to categorize assets under Contraception, Vaginal Health, Reproductive Health/Menopause/Sexual Health, and Fertility.",
        "elementsJson": null,
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.144+00",
          "seconds": 3.343,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/4",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-4",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.04,
            "w": 0.5,
            "x": 0.02,
            "y": 0.95
          },
          "kind": "disclaimer",
          "text": "* The product candidates presented are in clinical or preclinical stage development and none are approved for use outside of a clinical trial. XACIATO is our only FDA approved product.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.144+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b0b66e6f-bf49-42f0-b3c4-b142fe1eccd4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.9,
            "x": 0.07,
            "y": 0.32
          },
          "kind": "list",
          "text": "Vaginal Health: XACIATO, DARE-VVA1, DARE-GML, DARE-LBT",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.144+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "17762557-2006-45c5-9b2c-08f3fa7456e7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.07,
            "y": 0.12
          },
          "kind": "list",
          "text": "Contraception: Ovaprene, DARE-204/214, DARE-LARC1, DARE-RH1",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.144+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c57bda0e-0ac8-4d73-975e-5943c8a73db3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.07,
            "y": 0.75
          },
          "kind": "list",
          "text": "Fertility: DARE-FRT1/PTB1, DARE-PTB2",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.144+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dc8ac7f3-4ace-4bdc-8a7c-b0554395861d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.07,
            "y": 0.55
          },
          "kind": "list",
          "text": "Reproductive Health/Menopause/Sexual Health: Sildenafil Cream, DARE-HRT1, DARE-PDM1",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.144+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ff3efd22-4536-4021-a251-37698bfd41da",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.45,
            "x": 0.07,
            "y": 0.04
          },
          "kind": "title",
          "text": "Daré Portfolio – The Big Ideas*",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.144+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ea74b08e-ab9e-4994-911c-28ee4224ba33",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 5,
      "type": "resolution",
      "title": "The slide uses a Gantt-style chart to map product development stages against clinical phases.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 31,
        "componentCount": 4,
        "textChars": 263,
        "nDataPoints": 0,
        "notes": "The slide uses a Gantt-style chart to map product development stages against clinical phases.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:59.209+00",
          "seconds": 4.378,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/5",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-5",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.75,
            "x": 0.06,
            "y": 0.16
          },
          "kind": "chart",
          "text": "Clinical development timeline for XACIATO, Ovaprene, Sildenafil Cream, DARE-HRT1, and DARE-VVA1",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "timeline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.209+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "683b0389-9009-436d-9af8-de7a55a47a72",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "framework",
          "text": "Clinical development pipeline timeline",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Framework",
              "slug": "framework",
              "status": "active",
              "canonId": "019de52c-fa18-77c6-b10a-ccb8277ac0fa",
              "version": 1,
              "description": "Named conceptual framework instance."
            },
            "tool": null,
            "subkind": {
              "name": "Framework instance",
              "slug": "instance",
              "status": "active",
              "canonId": "019de52d-05a2-72af-be0b-7edc60708a03",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "instance",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.209+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "31c805e9-cce2-4cde-8f75-6db7a335a977",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.18,
            "x": 0.792,
            "y": 0.235
          },
          "kind": "paragraph",
          "text": "Organon and Daré are working towards a 2023 U.S. launch as soon as feasible*",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.209+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ba0382fd-ab9e-4aeb-9406-8cd5bf4a14f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.08,
            "y": 0.04
          },
          "kind": "title",
          "text": "Advancing Products Women Want – The Portfolio Snapshot",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.209+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6dcb7c0d-921a-4a8e-b230-ff715b4459e7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Deploy / Reshape / Invent (BCG)",
            "slug": "bcg-deploy-reshape-invent",
            "status": "active",
            "bestFor": null,
            "canonId": "019de52d-2044-72cc-b402-2511b4663d84",
            "version": 1,
            "bodyDocId": null,
            "description": null,
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "00cc175b-337d-4cd1-90a5-c0a5b5a3f78f",
          "evidence": "Clinical development timeline for XACIATO, Ovaprene, Sildenafil Cream, DARE-HRT1, and DARE-VVA1",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:58:22.063696+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 5,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "8b62473b-abda-4b4f-83b9-28baefd09957",
          "evidence": "Visual timeline mapping project phases over time",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 11:39:59.209+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 5,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 6,
      "type": "resolution",
      "title": "The slide uses a Gantt-style layout to track drug development progress.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 27,
        "componentCount": 4,
        "textChars": 200,
        "nDataPoints": 0,
        "notes": "The slide uses a Gantt-style layout to track drug development progress.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:57.947+00",
          "seconds": 3.092,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/6",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-6",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.75,
            "w": 0.84,
            "x": 0.08,
            "y": 0.125
          },
          "kind": "chart",
          "text": "Pipeline development status table",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "gantt-chart",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0da9abc3-6b51-476b-bc70-b9c85c0a571b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.74,
            "y": 0.95
          },
          "kind": "disclaimer",
          "text": "^505(b)(2) regulatory pathway anticipated. * Currently anticipated timing",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cfa2c17b-4f68-4f79-83da-aeab9f24fe30",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.22,
            "x": 0.08,
            "y": 0.115
          },
          "kind": "legend",
          "text": "Grant funding / Development collaborator",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "60f2764c-2d8d-452a-8a75-843fde8a4196",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.68,
            "x": 0.08,
            "y": 0.04
          },
          "kind": "title",
          "text": "Advancing Products Women Want – The Portfolio Snapshot",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e10594cf-1ff3-4488-877e-266130088c8f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Gantt chart",
            "slug": "gantt-chart",
            "status": "active",
            "bestFor": null,
            "canonId": "019de52d-1fa2-7206-bb14-bb9ff5fccdba",
            "version": 1,
            "bodyDocId": null,
            "description": null,
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "2fea0c07-4efe-4339-a5fd-67f99760a335",
          "evidence": "Pipeline development status table",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 03:58:22.14795+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 6,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "bff9020a-4a38-4e34-9728-123119d26a34",
          "evidence": "Visual representation of project phases over time",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 11:39:57.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 6,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 7,
      "type": "resolution",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 28,
        "componentCount": 3,
        "textChars": 266,
        "nDataPoints": 1,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:57.614+00",
          "seconds": 2.736,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/7",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-7",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.053,
            "w": 0.61,
            "x": 0.195,
            "y": 0.458
          },
          "kind": "paragraph",
          "text": "Potential First-In-Category treatment for Female Sexual Arousal Disorder (FSAD), and/or Female Sexual Interest/Arousal Disorder (FSIAD), which have no FDA-approved therapies",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.614+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3f3c6297-5776-4a79-aa48-c53178d9f0f4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.025,
            "w": 0.544,
            "x": 0.228,
            "y": 0.673
          },
          "kind": "paragraph",
          "text": "Novel cream formulation of sildenafil, the active ingredient in Viagra®",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.614+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8d6d7b67-1417-48f7-afb0-2e364c6b8a9e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.044,
            "w": 0.384,
            "x": 0.308,
            "y": 0.378
          },
          "kind": "title",
          "text": "Sildenafil Cream, 3.6%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:57.614+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "289ce354-7d22-4fd1-a9ea-23e898a02192",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 9,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 7,
          "name": "Solution",
          "beatId": "188fa255-ca44-4d79-b6ab-0aff1c2bb57b",
          "matchId": "0b2578b2-1add-4a04-bc3d-ab9bef32079b",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents solutions, including Sildenafil Cream, 3.6%, on pages 7-9",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 8,
      "type": "tension",
      "title": "The slide uses a comparison to erectile dysfunction to frame the market opportunity.",
      "function": "frame_problem",
      "rawType": "problem_statement",
      "block": null,
      "metadata": {
        "slideType": "problem_statement",
        "slideTypeCanon": {
          "name": "Problem statement",
          "slug": "problem_statement",
          "status": "active",
          "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4",
          "version": 1,
          "description": null
        },
        "function": "frame_problem",
        "functionCanon": {
          "name": "Frame problem",
          "slug": "frame_problem",
          "status": "active",
          "canonId": "019de52d-13db-753e-ad70-e9b2d0dab398",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 69,
        "componentCount": 5,
        "textChars": 2777,
        "nDataPoints": 4,
        "notes": "The slide uses a comparison to erectile dysfunction to frame the market opportunity.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:59.271+00",
          "seconds": 3.889,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/8",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-8",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.6,
            "x": 0.2,
            "y": 0.75
          },
          "kind": "callout",
          "text": "There are no FDA-approved treatments for FSAD/FSIAD",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d379234b-f607-41f9-898f-c32a8edab7b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.96,
            "x": 0.02,
            "y": 0.85
          },
          "kind": "disclaimer",
          "text": "1. Diagnostic and Statistical Manual (DSM) 4th Edition Text Revision (DSM IV TR) defines FSAD as a persistent or recurrent inability to attain or to maintain until completion of the sexual activity, an adequate lubrication-swelling response of sexual excitement. The diagnostic criteria also state that the inability causes marked distress or interpersonal difficulty, is not better accounted for by another Axis I disorder (except another sexual dysfunction) and is not due exclusively to the direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a general medical condition. As described in the fifth edition of the DSM (DSM 5), which was published in 2013, FSIAD is characterized as lack of, or significantly reduced, sexual interest and/or arousal for at least six months and the symptoms must be severe enough to cause clinically significant distress. Patients could meet the DSM 5 criteria for FSIAD if they predominantly have symptoms of low sexual interest, if they predominantly have symptoms of low sexual arousal, or if they predominantly have symptoms of both low sexual desire and low sexual arousal. 2. https://labs.la.utexas.edu/mestonlab/female-sexual-interestarousal-disorders/, accessed 8 August 2023 3. https://my.clevelandclinic.org/health/diseases/24640-anorgasmia, accessed 8 August 2023 4. McCool et al. Sex Med Rev 2016;4:197-212. DOI: 10.1016/j.sxmr.2016.03.002 5. Ad Hoc Market Research: FSAD Prevalence Report (Oct 2015) conducted for SST LLC. 6. Based on US Census projections for 2016.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f83b4a63-fb19-4f89-9182-44a737483068",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.45,
            "x": 0.52,
            "y": 0.18
          },
          "kind": "list",
          "text": "Meta-analysis of 95 studies from 2000-2014 indicated prevalence of Female Sexual Dysfunction in premenopausal women worldwide is 41%, and difficulty with arousal alone is 23%. Market research estimates: 33% of US women aged 21 to 60 (~ 20 million women), experience symptoms of low or no sexual arousal. 10 million women are considered distressed and actively seeking treatment.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2eb62b64-d25a-4979-a90f-b2e56fe140ce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.45,
            "x": 0.05,
            "y": 0.18
          },
          "kind": "list",
          "text": "Female Sexual Arousal Disorder (FSAD) is characterized primarily by inability to attain or maintain sufficient genital arousal during sexual activity and, Female Sexual Interest/Arousal Disorder (FSIAD) is defined in the DSM-5 as lack of, or significantly reduced, sexual interest/arousal. Of female sexual function disorders, these conditions are those most analogous to erectile dysfunction (ED) in men. Arousal disorders in women should be distinguished from a general loss of interest in sexual activity and from other sexual dysfunctions, such as orgasmic disorder (anorgasmia) and hypoactive sexual desire disorder (HSDD), which is characterized in DSM-IV-TR as lack or absence of sexual fantasies and desire for sexual activity for some period of time.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aa24f1ed-a7ab-4d72-9dc7-d25f1b567032",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.64,
            "x": 0.18,
            "y": 0.03
          },
          "kind": "title",
          "text": "FSAD/FSIAD – The Clinical Issue & Prevalence",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e1ca5fad-9990-4bbc-93b1-13776516fced",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Problem Statement Canvas",
            "slug": "problem-statement-canvas",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18",
            "version": 1,
            "bodyDocId": null,
            "description": "Structured definition of the problem: What? Who? Where? When? Scale?",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Architect",
          "layer": "slide",
          "agents": [
            "Architect"
          ],
          "matchId": "63ce8606-bbcb-4aef-8e39-ce555aadd0c0",
          "evidence": "Female Sexual Arousal Disorder (FSAD) is characterized primarily by inability to attain or maintain sufficient genital arousal during sexual activity",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:58:22.270656+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 8,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "ef04e9f6-209c-4a71-bc43-746e83186b8a",
          "evidence": "Comparison of FSAD/FSIAD to erectile dysfunction (ED) in men.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:39:59.271+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 8,
          "frameworkName": "argument-from-analogy"
        }
      ],
      "arcBeats": [
        {
          "to": 8,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Problem",
          "beatId": "7d9cc53d-18a2-4032-9a7e-ce50d00a7876",
          "matchId": "0b2578b2-1add-4a04-bc3d-ab9bef32079b",
          "beatType": {
            "name": "Problem",
            "slug": "sequoia-pitch-problem",
            "status": "active",
            "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a clear problem statement on page 8",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 9,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 7,
          "name": "Solution",
          "beatId": "188fa255-ca44-4d79-b6ab-0aff1c2bb57b",
          "matchId": "0b2578b2-1add-4a04-bc3d-ab9bef32079b",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents solutions, including Sildenafil Cream, 3.6%, on pages 7-9",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 11,
          "from": 8,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "83faa245-7d21-49f3-aa4d-68f21da0e116",
          "evidence": "The deck presents the consequences of not addressing FSAD/FSIAD on pages 8-11",
          "position": 0,
          "objective": "Highlight the need for a treatment for FSAD/FSIAD",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:36:02.645468+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 9,
      "type": "resolution",
      "title": "The slide uses a yellow underline to emphasize the lack of FDA-approved treatments.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 4,
        "textChars": 958,
        "nDataPoints": 1,
        "notes": "The slide uses a yellow underline to emphasize the lack of FDA-approved treatments.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.955+00",
          "seconds": 3.561,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/9",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-9",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.55,
            "w": 0.9,
            "x": 0.07,
            "y": 0.23
          },
          "kind": "list",
          "text": "A PDE5 inhibitor utilized in ED medications for men – ED product Viagra® peaked at $2.05 billion in sales in 2012.²\nDesigned to increase local blood flow to promote improved genital arousal response.\nApplied topically, avoiding hepatic first-pass metabolism response, resulting in lower systemic exposure potentially resulting in reduced side effects vs. oral sildenafil, including Viagra®.\nGiven similarities between ED and FSAD, sildenafil - the active ingredient in Viagra® - may improve genital arousal response and overall sexual experience for women as it does in men.\nThere are no FDA-approved treatments for FSAD or FSIAD.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.955+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7600ca54-1b12-4549-b531-d578a5ead14a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.55,
            "x": 0.07,
            "y": 0.17
          },
          "kind": "paragraph",
          "text": "Topically-administered investigational Sildenafil Cream¹ is...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.955+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2fdf9bcf-5971-42c2-8984-e6122c4ebd75",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.35,
            "x": 0.07,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "1. Sildenafil Cream, 3.6%, (formerly SST-6007)\n2. https://qz.com/quartzy/1238783/its-the-20th-anniversary-of-viagra-heres-how-its-changed-the-world/#:~:text=Annual%20sales%20of%20Viagra%20peaked,Viagra%2020%20set%20to%20expire",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.955+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d34cce89-ba8c-4e4a-9432-23d69e83d24d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.62,
            "x": 0.07,
            "y": 0.04
          },
          "kind": "title",
          "text": "Sildenafil Cream, 3.6% - Product Profile",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.955+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "658ebf90-eb08-4a3c-8044-441a0dfab432",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 9,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 7,
          "name": "Solution",
          "beatId": "188fa255-ca44-4d79-b6ab-0aff1c2bb57b",
          "matchId": "0b2578b2-1add-4a04-bc3d-ab9bef32079b",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents solutions, including Sildenafil Cream, 3.6%, on pages 7-9",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 11,
          "from": 8,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "83faa245-7d21-49f3-aa4d-68f21da0e116",
          "evidence": "The deck presents the consequences of not addressing FSAD/FSIAD on pages 8-11",
          "position": 0,
          "objective": "Highlight the need for a treatment for FSAD/FSIAD",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:36:02.645468+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 10,
      "type": "analysis",
      "title": "The slide outlines the methodology and endpoints of a clinical trial.",
      "function": "analyze_data",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 52,
        "componentCount": 4,
        "textChars": 985,
        "nDataPoints": 0,
        "notes": "The slide outlines the methodology and endpoints of a clinical trial.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.673+00",
          "seconds": 3.165,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/10",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-10",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.45,
            "w": 0.94,
            "x": 0.03,
            "y": 0.27
          },
          "kind": "list",
          "text": "Compared Sildenafil Cream vs. placebo used in patients' home setting.\nCo-primary endpoints: patient reported outcome (PRO) instruments measured improvement in localized genital sensations of arousal (Arousal-Sensation Domain of the Sexual Function Questionnaire) and reduction in FSAD related distress (Female Sexual Distress Scale).\nSecondary endpoint: measured change in the number of satisfactory sexual events\nExploratory endpoints: Several efficacy endpoints measured and could be candidate endpoints in a Phase 3 study. Efficacy assessments were administered both on an electronic diary to be completed within 24 hours of a sexual event and via 28-day recall assessments.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0e707e17-ca9b-4990-871c-3d06765c8d64",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.94,
            "x": 0.03,
            "y": 0.17
          },
          "kind": "paragraph",
          "text": "Exploratory Phase 2b clinical study designed to evaluate Sildenafil Cream vs. placebo over 12 weeks of double-blinded dosing following both a non-drug and placebo run-in period",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "88bf86d8-c037-4681-a6d4-330190a9bca6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.64,
            "x": 0.18,
            "y": 0.81
          },
          "kind": "paragraph",
          "text": "Topline data of exploratory Phase 2b RESPOND study announced June 5, 2023.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bf8e0d70-6996-4133-aba9-fe003cc88874",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.92,
            "x": 0.07,
            "y": 0.04
          },
          "kind": "title",
          "text": "Sildenafil Cream, 3.6% - Phase 2b RESPOND Study - Overview",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1eb8ade7-c594-45a6-8d8c-3e5affa49e39",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 11,
          "from": 8,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "83faa245-7d21-49f3-aa4d-68f21da0e116",
          "evidence": "The deck presents the consequences of not addressing FSAD/FSIAD on pages 8-11",
          "position": 0,
          "objective": "Highlight the need for a treatment for FSAD/FSIAD",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:36:02.645468+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 11,
      "type": "evidence",
      "title": "The slide highlights clinical trial outcomes and regulatory next steps.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 69,
        "componentCount": 6,
        "textChars": 1014,
        "nDataPoints": 0,
        "notes": "The slide highlights clinical trial outcomes and regulatory next steps.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:21:42.002+00",
          "seconds": 4.938,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/11",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-11",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.72,
            "x": 0.14,
            "y": 0.81
          },
          "kind": "callout",
          "text": "Preparing to Request End-of-Phase 2 Meeting with FDA",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:21:42.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d49fae4-9ce6-4fb6-a281-369eca29a5c6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.94,
            "x": 0.03,
            "y": 0.31
          },
          "kind": "list",
          "text": "Sildenafil Cream-treated group showed meaningful improvement in the co-primary endpoint assessment that evaluated change from baseline in the Arousal-Sensation Domain of the Sexual Function Questionnaire, although the endpoint did not achieve statistical significance.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:21:42.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d568c445-8be3-4a53-9294-0fbbae43645c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.94,
            "x": 0.03,
            "y": 0.45
          },
          "kind": "list",
          "text": "Sildenafil Cream-treated group also showed improvements in the secondary endpoint and pre-specified exploratory endpoints that evaluated various aspects of the sexual experience: Sexual satisfaction, Arousal lubrication, Achievement and pleasure of orgasm, Sexual desire",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:21:42.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fe6a2d5a-d928-4cd3-9b22-288fd77b34f8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.94,
            "x": 0.03,
            "y": 0.17
          },
          "kind": "paragraph",
          "text": "Positive findings from the exploratory Phase 2b RESPOND study of Sildenafil Cream, 3.6% in women with Female Sexual Arousal Disorder support continued development of Sildenafil Cream and selection of proposed primary endpoint assessments for a Phase 3 study",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:21:42.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c6fbd800-84ef-4a98-84ec-5e1fe79fcfde",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.03,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "1. The study did not demonstrate statisitcal significance for the co-primary or seconday efficacy enpoints.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:21:42.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5430c7ab-c092-4b7f-9404-9c3f1299e338",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.86,
            "x": 0.07,
            "y": 0.04
          },
          "kind": "title",
          "text": "Sildenafil Cream, 3.6% - Phase 2b RESPOND Study – Highlights",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:21:42.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34927605-8ef1-48de-a513-7109867e422b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 11,
          "from": 8,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "83faa245-7d21-49f3-aa4d-68f21da0e116",
          "evidence": "The deck presents the consequences of not addressing FSAD/FSIAD on pages 8-11",
          "position": 0,
          "objective": "Highlight the need for a treatment for FSAD/FSIAD",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:36:02.645468+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 12,
      "type": "resolution",
      "title": "The slide serves as a transition or focus slide for the company's lead product.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 42,
        "componentCount": 6,
        "textChars": 174,
        "nDataPoints": 0,
        "notes": "The slide serves as a transition or focus slide for the company's lead product.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.761+00",
          "seconds": 3.186,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/12",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-12",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.045,
            "w": 0.025,
            "x": 0.375,
            "y": 0.816
          },
          "kind": "image",
          "text": "Bayer logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1f6788ca-84f5-44b9-86f4-eccf66530d70",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.045,
            "w": 0.032,
            "x": 0.597,
            "y": 0.816
          },
          "kind": "image",
          "text": "NIH logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "252c1d61-596b-4aa2-9726-e63f666d154d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.025,
            "w": 0.61,
            "x": 0.195,
            "y": 0.471
          },
          "kind": "paragraph",
          "text": "Investigational potential first-in-category, hormone-free, monthly birth control",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dca0eea4-0890-405a-8036-161b0d2a67ba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.015,
            "w": 0.158,
            "x": 0.534,
            "y": 0.879
          },
          "kind": "subtitle",
          "text": "Phase 3 Development Collaborator",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "82d821ee-2793-42e7-8f16-c6131385a3ce",
              "version": 1,
              "description": "Header-zone supporting text near the title (= ex body.description with bbox)."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5d0df228-85af-4808-8663-05d85a565130",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.015,
            "w": 0.155,
            "x": 0.31,
            "y": 0.879
          },
          "kind": "subtitle",
          "text": "U.S. Commercialization Collaborator",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "82d821ee-2793-42e7-8f16-c6131385a3ce",
              "version": 1,
              "description": "Header-zone supporting text near the title (= ex body.description with bbox)."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7c449d09-3700-4f3e-a4aa-5dd40e1395e5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.045,
            "w": 0.194,
            "x": 0.403,
            "y": 0.395
          },
          "kind": "title",
          "text": "Ovaprene®",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "938ee7c0-e577-4523-97dd-cf9467e3f80b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 13,
      "type": "resolution",
      "title": "Includes specific revenue data for Mirena, Lo Loestrin, and NuvaRing as market benchmarks.",
      "function": "size_opportunity",
      "rawType": "market_sizing",
      "block": null,
      "metadata": {
        "slideType": "market_sizing",
        "slideTypeCanon": {
          "name": "Market sizing",
          "slug": "market_sizing",
          "status": "active",
          "canonId": "019de52d-08c8-756c-8664-733b73a7ee7b",
          "version": 1,
          "description": null
        },
        "function": "size_opportunity",
        "functionCanon": {
          "name": "Size opportunity",
          "slug": "size_opportunity",
          "status": "active",
          "canonId": "019de52d-147b-7568-8828-a74a27697618",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 73,
        "componentCount": 6,
        "textChars": 688,
        "nDataPoints": 12,
        "notes": "Includes specific revenue data for Mirena, Lo Loestrin, and NuvaRing as market benchmarks.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.542+00",
          "seconds": 2.902,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/13",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-13",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.7,
            "w": 0.45,
            "x": 0.52,
            "y": 0.15
          },
          "kind": "chart",
          "text": "Successful Contraceptive Brands Peak Sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Bubble chart",
              "slug": "bubble",
              "status": "active",
              "canonId": "019de52d-00a4-756f-8978-8d5e48905dbc",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bubble",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.542+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c74d6e3e-e81a-4253-91e8-f95867861975",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.07,
            "y": 0.205
          },
          "kind": "paragraph",
          "text": "Women in the Reproductive Health & Contraception Market Segment (over 60 million women)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.542+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1e908cee-c1b7-4f77-8c9b-dc88934be60f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.01,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "1. https://www.bayer.com/en/bayer-ag-annual-report-2019.pdfx. Includes sales for Mirena, Kyleena and Jaydess / Skyla. 2. https://www.prnewswire.com/news-releases/allergan-reports-fourth-quarter-and-full-year-2019-financial-results-301001646.html 3. https://www.sec.gov/Archives/edgar/data/0000310158/000031015819000014/mrk1231201810k.htm",
          "attrs": {
            "numbered": true
          },
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.542+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "329b96f3-a075-4264-8826-2d0faff00ee7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.35,
            "x": 0.07,
            "y": 0.72
          },
          "kind": "source-note",
          "text": "Sources: US Census Bureau. Population estimates based on bridged race categories released by the National Center for Health Statistics.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.542+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9182397e-d052-47cb-bf0c-8e5054653747",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.45,
            "x": 0.07,
            "y": 0.3
          },
          "kind": "table",
          "text": "Population of women 15-44 years by age: US, 2020",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.542+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f7abb47-b47d-4877-9ab5-9fa7ff49a820",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.5,
            "x": 0.07,
            "y": 0.04
          },
          "kind": "title",
          "text": "Contraception: Large Market Opportunity",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.542+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "df60d505-f7c6-45b3-b655-9b3ac3dd639a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "7c2464fc-2a95-4055-90ca-cad2b681cc1d",
          "evidence": "Quantifies total addressable population and benchmarks against competitor revenue.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:39:58.542+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 13,
          "frameworkName": "market-sizing"
        }
      ],
      "arcBeats": [
        {
          "to": 13,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 13,
          "name": "Market Size",
          "beatId": "663a8ca0-0fa2-4b77-883d-caaa97effcc5",
          "matchId": "0b2578b2-1add-4a04-bc3d-ab9bef32079b",
          "beatType": {
            "name": "Market Size",
            "slug": "sequoia-pitch-market-size",
            "status": "active",
            "canonId": "019dd9b8-20e6-729c-bc28-05442906d032",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents market sizing information on page 13",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 14,
      "type": "setup",
      "title": "The slide uses a vertical axis to represent effectiveness, positioning the company's proposed solution between existing barrier methods and the Copper IUD.",
      "function": "compare_peers",
      "rawType": "comparison_table",
      "block": null,
      "metadata": {
        "slideType": "comparison_table",
        "slideTypeCanon": {
          "name": "Comparison table",
          "slug": "comparison_table",
          "status": "active",
          "canonId": "019de52d-0a06-73f8-8813-fe022fab1de2",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 55,
        "componentCount": 5,
        "textChars": 424,
        "nDataPoints": 4,
        "notes": "The slide uses a vertical axis to represent effectiveness, positioning the company's proposed solution between existing barrier methods and the Copper IUD.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.783+00",
          "seconds": 3.065,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/14",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-14",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.9
          },
          "kind": "disclaimer",
          "text": "U.S. Food and Drug Administration Birth Control Guide... Pregnancy rates tell you the number of pregnancies expected per 100 women during the first year of typical use.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.783+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7e8a1959-9157-42dd-94f9-7d9fa0433743",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.2,
            "x": 0.14,
            "y": 0.32
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.783+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2fe8aaca-b869-4987-b518-8112f0e4e20b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.05,
            "x": 0.78,
            "y": 0.25
          },
          "kind": "legend",
          "text": "Least Effective to Most Effective arrow",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.783+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f3577e5e-d344-424b-a16d-b0bbc0463452",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.45,
            "x": 0.32,
            "y": 0.25
          },
          "kind": "table",
          "text": "Spermicides & Vaginal Gels (>27), Condoms (18), Diaphragms (12), Easy-to-use monthly option (Effectiveness approaching hormonal methods), Copper IUD (<1)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.783+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a8d015c6-1c9c-4163-b535-2120e1b3b01a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.6,
            "x": 0.07,
            "y": 0.05
          },
          "kind": "title",
          "text": "Contraception: What's Missing from Current Hormone-Free Options?",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.783+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ae8ef082-c24d-4a68-b7ed-3975ec21e323",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "98c39a80-f9a3-49c4-852f-ec026beb4970",
          "evidence": "Comparing existing contraceptive methods against a new proposed solution on a spectrum of effectiveness.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:39:58.783+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 14,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 15,
      "type": "appendix",
      "title": "Includes a quote from a Bayer executive regarding the collaboration.",
      "function": "cite_precedent",
      "rawType": "other",
      "block": null,
      "metadata": {
        "slideType": "other",
        "slideTypeCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43",
          "version": 1,
          "description": null
        },
        "function": "cite_precedent",
        "functionCanon": {
          "name": "Cite precedent",
          "slug": "cite_precedent",
          "status": "active",
          "canonId": "019de52d-142b-714b-86d4-58aad7b568ec",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 75,
        "componentCount": 6,
        "textChars": 1135,
        "nDataPoints": 2,
        "notes": "Includes a quote from a Bayer executive regarding the collaboration.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.511+00",
          "seconds": 2.784,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/15",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-15",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.05,
            "y": 0.48
          },
          "kind": "image",
          "text": "NIH Cooperative Research and Development Agreement (CRADA) for the Pivotal Phase 3 Study",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.511+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a23aa12a-4672-4d76-a490-9fd3ece294ef",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.7,
            "w": 0.45,
            "x": 0.52,
            "y": 0.2
          },
          "kind": "list",
          "text": "The pivotal Phase 3 study will be supported by the NICHD’s Contraceptive Development Program... Daré will be responsible for providing clinical supplies... Under the CRADA, Daré also agreed to contribute $5.5 million toward the total estimated cost...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.511+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "36f680e7-8ca0-4061-8d55-a9e278fba381",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.45,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "list",
          "text": "July 2021 – Daré announced that funding and clinical operations support for the Phase 3 will be provided by the National Institutes of Health’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the CRADA",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.511+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "48add204-7828-4a0e-ac1c-f4aa2a1670c4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.45,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "quote",
          "text": "This collaboration between Daré and NICHD marks an important milestone in Women’s Healthcare Innovation. Women are at the center of everything we do and we are so pleased to continue to partner with Daré in support of our mission We’re For Her to provide women with education and access to contraceptive options, said John Berrios, Bayer’s Head of Women’s Healthcare.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.511+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b934ce62-d540-46f4-bdb8-20b1947da728",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.5,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "1. https://ir.darebioscience.com/news-releases/news-release-details/dare-announces-collaborative-research-agreement-crada-pivotal",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.511+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "54de36cd-7a46-4805-b659-da6d82600e31",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Ovaprene® - Collaborative Research Agreement with NIH",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.511+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee4d5392-fb6d-451b-bb2d-335a91e4c013",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Social Proof",
            "slug": "social-proof",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-990d-7620-82b3-6dd286f34568",
            "version": 1,
            "bodyDocId": null,
            "description": "People adapt behavior based on what others do - show adoption and testimonials",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "d416ae37-87f8-4f57-8201-f99b8579bad0",
          "evidence": "image/logo: NIH Cooperative Research and Development Agreement (CRADA) for the Pivotal Phase 3 Study",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:28:52.362753+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 15,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 16,
      "type": "analysis",
      "title": "Includes clinical trial data table and regulatory roadmap steps.",
      "function": "analyze_data",
      "rawType": "appendix_methodology",
      "block": null,
      "metadata": {
        "slideType": "appendix_methodology",
        "slideTypeCanon": {
          "name": "Appendix methodology",
          "slug": "appendix_methodology",
          "status": "active",
          "canonId": "019de52d-07d9-726c-8599-167f2d2ffaa7",
          "version": 1,
          "description": null
        },
        "function": "analyze_data",
        "functionCanon": {
          "name": "Analyze data",
          "slug": "analyze_data",
          "status": "active",
          "canonId": "019de52d-1590-7413-8c82-cc218cff40b4",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 7,
        "textChars": 916,
        "nDataPoints": 8,
        "notes": "Includes clinical trial data table and regulatory roadmap steps.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:59.384+00",
          "seconds": 3.55,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/16",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-16",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.43,
            "x": 0.05,
            "y": 0.28
          },
          "kind": "list",
          "text": "Ovaprene prevented the requisite number of sperm from reaching the cervix across all women and all cycles evaluated. Specifically, in 100% of women and cycles, an average of less than five (< 5) progressively motile sperm (PMS) per high-powered field (HPF) were present in the midcycle cervical mucus collected two to three hours after intercourse with Ovaprene in place.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.384+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2d10b59e-0909-40e2-a591-48bcc785f2e9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.45,
            "x": 0.49,
            "y": 0.3
          },
          "kind": "list",
          "text": "Step 1 (Completed): PCT Study. Step 2 (Ongoing): 1. FDA approval of IDE, 2. Review study design, 3. Conduct pivotal study.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Numbered list",
              "slug": "numbered",
              "status": "active",
              "canonId": "019de52c-fcc0-7718-a284-a4250c805df2",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "numbered",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.384+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ece5b061-e99c-4539-ba28-9a56b44623d3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.4,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "paragraph",
          "text": "The PCT Clinical Study Met its Primary Endpoint",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.384+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "799c24a5-a643-4e4c-8bae-b4fb102b6cf0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.45,
            "x": 0.49,
            "y": 0.2
          },
          "kind": "paragraph",
          "text": "Premarket approval (PMA) strategy. The Center for Devices and Radiological Health (CDRH) as lead review division.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.384+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a335cf1d-7410-4e4d-9f3d-c6142ceee65c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.95,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "1. Anticipated regulatory pathway and timelines. 2. Mauck C., Vincent K. Biology of Reproduction, Volume 103, Issue 2, August 2020, Pages 437-444",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.384+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5fd0f8e3-c8c1-40ea-b091-8b15fbad490f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.44,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "table",
          "text": "Baseline PCT's: 27.21, 23.20, 17.88, 24.80. Ovaprene PCT's: 0.48, 0.00, 1.18, 0.10.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.384+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9e573757-b921-4dd5-bb39-a0214934e75e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.54,
            "x": 0.23,
            "y": 0.03
          },
          "kind": "title",
          "text": "Ovaprene - U.S. Regulatory Strategy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.384+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dac3352b-703d-4d6a-b010-e1058c164ff8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Table data",
            "slug": "table-data",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4fab-7168-a82f-b847350a006d",
            "version": 1,
            "bodyDocId": null,
            "description": "Tabular layouts of structured data.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "480e03ed-613f-42a3-a16a-e09087f2af96",
          "evidence": "table/data: Baseline PCT's: 27.21, 23.20, 17.88, 24.80. Ovaprene PCT's: 0.48, 0.00, 1.18, 0.10.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 00:28:52.440546+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 16,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 17,
      "type": "evidence",
      "title": "Includes a yellow highlight on the $310 million milestone figure.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 8,
        "textChars": 1283,
        "nDataPoints": 3,
        "notes": "Includes a yellow highlight on the $310 million milestone figure.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:59.71+00",
          "seconds": 3.856,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/17",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-17",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.08,
            "x": 0.15,
            "y": 0.56
          },
          "kind": "image",
          "text": "Bayer logo",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "091feda2-a7af-434c-b56e-cd6487ac89bf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.45,
            "x": 0.5,
            "y": 0.57
          },
          "kind": "list",
          "text": "Bayer supports the development and regulatory process by providing up to two full-time equivalents (internal experts) in an advisory capacity, which gives Daré access to their global manufacturing, regulatory, medical and commercial expertise.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0aaa2abf-be2d-4ece-8e82-4f1f4e9fc347",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.45,
            "x": 0.5,
            "y": 0.22
          },
          "kind": "list",
          "text": "Bayer received the right to obtain exclusive US rights to commercialize the product, following completion of the pivotal clinical trial if Bayer, in its sole discretion, pays Daré $20 million.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34af6302-52f5-4f8a-98de-2ea7eb26da42",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.45,
            "x": 0.5,
            "y": 0.43
          },
          "kind": "list",
          "text": "Daré may receive up to $310 million in commercial milestone payments, plus double-digit, tiered royalties on net sales.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7a08f1e7-60f8-44ea-aca7-75cc4744c09c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.42,
            "x": 0.05,
            "y": 0.22
          },
          "kind": "list",
          "text": "January 2020 - Bayer, which markets the $1 billion Mirena contraceptive franchise, and Daré announced the execution of a license agreement under which Bayer may commercialize Ovaprene investigational contraceptive in the US once approved by FDA.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cd80e6d1-845d-4d64-bedd-8c8d74c51176",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.83
          },
          "kind": "paragraph",
          "text": "We believe the licensing agreement with Bayer is validation of our broader corporate strategy and confirmation of Ovaprene’s market potential, if approved, as the first monthly non-hormonal contraceptive product in the US market.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ac75e397-1921-45bd-94d7-34ec8bf2c58a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "* https://www.mirena-us.com/; supported by 2014-2016 SHS data. 1.https://ir.darebioscience.com/news-releases/news-release-details/bayer-and-dare-bioscience-announce-exclusive-licensing-agreement",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c31b5d54-894c-4f82-b15f-f0113704b615",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.78,
            "x": 0.11,
            "y": 0.03
          },
          "kind": "title",
          "text": "Ovaprene® - Commercial License Agreement with Bayer",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.71+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6a3f4a64-e736-4eff-a8f9-75709f46f87e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 18,
      "type": "setup",
      "title": "This slide serves as a formal product introduction/disclaimer page.",
      "function": "other",
      "rawType": "disclaimer",
      "block": null,
      "metadata": {
        "slideType": "disclaimer",
        "slideTypeCanon": {
          "name": "Disclaimer",
          "slug": "disclaimer",
          "status": "active",
          "canonId": "019de52d-0801-727b-b98a-5ed095aeee78",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 36,
        "componentCount": 4,
        "textChars": 343,
        "nDataPoints": 0,
        "notes": "This slide serves as a formal product introduction/disclaimer page.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.206+00",
          "seconds": 2.132,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/18",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-18",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.42,
            "x": 0.29,
            "y": 0.65
          },
          "kind": "disclaimer",
          "text": "XACIATO is indicated for the treatment of bacterial vaginosis in females 12 years and older. See Full Prescribing Information for the safe and effective use of XACIATO. See XACIATO selected safety information on slide 21.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.206+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "64ce5234-f121-48c7-876c-6712181128f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.12,
            "x": 0.44,
            "y": 0.86
          },
          "kind": "image",
          "text": "ORGANON Commercialization Collaborator",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.206+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "20b80b5b-00aa-409e-bec9-26862f8338b8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.32,
            "x": 0.34,
            "y": 0.5
          },
          "kind": "paragraph",
          "text": "One-time intravaginal administration",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.206+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b84905fd-19d5-44d4-a4e3-96bdfc4a3d3b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.64,
            "x": 0.18,
            "y": 0.35
          },
          "kind": "title",
          "text": "XACIATO™ (Clindamycin Phosphate) Vaginal Gel, 2%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.206+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7e4c2814-dc37-45ce-8db1-5341bfb79476",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 19,
      "type": "evidence",
      "title": "The slide highlights a key partnership and associated financial milestones.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 67,
        "componentCount": 5,
        "textChars": 973,
        "nDataPoints": 3,
        "notes": "The slide highlights a key partnership and associated financial milestones.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:59.072+00",
          "seconds": 2.838,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/19",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-19",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.25,
            "w": 0.32,
            "x": 0.65,
            "y": 0.28
          },
          "kind": "callout",
          "text": "Daré received a $10 million upfront payment in 3Q 2022 and a $1 million payment in July 2023. Daré is eligible to receive potential milestone payments of up to $181.8 million and tiered double-digit royalties based on net sales.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.072+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "632fb0c9-70b9-4e1a-b0ab-ebf460b19d12",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.58,
            "x": 0.02,
            "y": 0.17
          },
          "kind": "list",
          "text": "March 2022 – Organon and Daré announced they entered into an agreement whereby Organon will license global rights to XACIATO. The license became effective June 2022.\nOrganon is a global healthcare company formed through a spin-off from Merck & Co.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.072+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5330d39e-1f2e-423b-9271-6de165bf0b38",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.74
          },
          "kind": "paragraph",
          "text": "We believe Organon shares our commitment to advance critically needed innovations in women’s health. We are excited to be collaborating with one of the premier companies in women’s health as we believe that Organon’s commercial capabilities will ensure that XACIATO reaches the women most impacted by bacterial vaginosis.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.072+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9eb235f5-04a5-4645-9f8a-0af901681b2a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.41,
            "x": 0.01,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "1. https://ir.darebioscience.com/news-releases/news-release-details/organon-enters-global-license-agreement-commercialize-dare",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.072+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7e9e9d56-e085-4e19-be2e-d4fd4eeb6add",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.86,
            "x": 0.07,
            "y": 0.04
          },
          "kind": "title",
          "text": "XACIATO - Commercial License Agreement with Organon",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.072+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6b0b0b1b-b32c-4142-97b0-697bef03c0f7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 20,
      "type": "setup",
      "title": "Includes regulatory status and go-to-market synergy with existing Organon product NEXPLANON.",
      "function": "present_solution",
      "rawType": "product_demo",
      "block": null,
      "metadata": {
        "slideType": "product_demo",
        "slideTypeCanon": {
          "name": "Product demo",
          "slug": "product_demo",
          "status": "active",
          "canonId": "019de52d-0f06-7288-84f2-7568c1020fce",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 69,
        "componentCount": 6,
        "textChars": 652,
        "nDataPoints": 1,
        "notes": "Includes regulatory status and go-to-market synergy with existing Organon product NEXPLANON.",
        "elementsJson": null,
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:59.709+00",
          "seconds": 3.319,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/20",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-20",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.04,
            "w": 0.35,
            "x": 0.03,
            "y": 0.31
          },
          "kind": "callout",
          "text": "Daré's first FDA-approved product.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.709+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "09ee8254-92d9-491b-8958-a9b5714f6816",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.428,
            "w": 0.118,
            "x": 0.814,
            "y": 0.169
          },
          "kind": "image",
          "text": "QIDP, Fast Track and Priority Review Designations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Infographic",
              "slug": "infographic",
              "status": "active",
              "canonId": "019de52c-fe26-750c-9d7d-9f34e21324e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "infographic",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.709+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "75991619-0348-460a-9e59-00cde473c907",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.75,
            "x": 0.03,
            "y": 0.37
          },
          "kind": "list",
          "text": "Organon and Daré are working towards a U.S. launch as soon as feasible. To provide for continuity of supply... Organon market access team meeting with customers... Organon will leverage the knowledge and experience of its established NEXPLANON sales team... Organon believes there is roughly a 90% overlap of healthcare providers...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.709+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cf4feb53-503d-468a-a583-24b7d596b1e3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.75,
            "x": 0.03,
            "y": 0.17
          },
          "kind": "paragraph",
          "text": "XACIATO [zah-she-AH-toe] (clindamycin phosphate) vaginal gel, 2% is a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.709+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "129c8188-5464-4ef6-aa0b-5a777485947b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.025,
            "w": 0.102,
            "x": 0.822,
            "y": 0.468
          },
          "kind": "paragraph",
          "text": "NDA Approved December 7, 2021",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.709+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ca65d213-e942-4181-a1fa-993bc70a435d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.35,
            "x": 0.07,
            "y": 0.04
          },
          "kind": "title",
          "text": "XACIATO Overview",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.709+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "97379082-1044-45e8-8142-afa916f75f29",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 21,
      "type": "setup",
      "title": "Standard pharmaceutical safety disclosure slide.",
      "function": "other",
      "rawType": "appendix_disclosure",
      "block": null,
      "metadata": {
        "slideType": "appendix_disclosure",
        "slideTypeCanon": {
          "name": "Appendix disclosure",
          "slug": "appendix_disclosure",
          "status": "active",
          "canonId": "019de52d-07b2-7549-8e8b-932a19f6e616",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 38,
        "componentCount": 2,
        "textChars": 582,
        "nDataPoints": 1,
        "notes": "Standard pharmaceutical safety disclosure slide.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:59.215+00",
          "seconds": 2.808,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/21",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-21",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.75,
            "w": 0.85,
            "x": 0.075,
            "y": 0.15
          },
          "kind": "list",
          "text": "XACIATO is contraindicated in individuals with a history of hypersensitivity to clindamycin or lincomycin. Clostridioides difficile-associated diarrhea (CDAD) has been reported... Polyurethane condoms are not recommended... XACIATO may result in the overgrowth of Candida spp... The most common adverse reactions reported in >2% of patients... XACIATO has not been studied in pregnant women... There are no data on the effect of clindamycin on milk production. Please see the Prescribing Information, Patient Information, and Instructions for Use.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.215+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "81f90f2a-3308-4493-8307-ec5782250c5b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.5,
            "x": 0.075,
            "y": 0.04
          },
          "kind": "title",
          "text": "XACIATO Selected Safety Information",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.215+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "38531449-bad0-4a05-b3a3-b52dfce9a1ca",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 22,
      "type": "setup",
      "function": "transition",
      "rawType": "section_divider",
      "block": null,
      "metadata": {
        "slideType": "section_divider",
        "slideTypeCanon": {
          "name": "Section divider",
          "slug": "section_divider",
          "status": "active",
          "canonId": "019de52d-066a-7402-9554-6ae504999041",
          "version": 1,
          "description": null
        },
        "function": "transition",
        "functionCanon": {
          "name": "Transition",
          "slug": "transition",
          "status": "active",
          "canonId": "019de52d-1365-7149-92aa-66df859e75fd",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 2,
        "componentCount": 1,
        "textChars": 19,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.666+00",
          "seconds": 2.246,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/22",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-22",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.44,
            "x": 0.28,
            "y": 0.4
          },
          "kind": "title",
          "text": "Commercial Planning",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.666+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ff2f5e96-21b3-4f5b-afbb-f8367ac0e49a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 23,
      "type": "resolution",
      "function": "plan_implementation",
      "rawType": "go_to_market",
      "block": null,
      "metadata": {
        "slideType": "go_to_market",
        "slideTypeCanon": {
          "name": "Go-to-market",
          "slug": "go_to_market",
          "status": "active",
          "canonId": "019de52d-0ff6-713a-bd55-53d4e90b2304",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 56,
        "componentCount": 4,
        "textChars": 848,
        "nDataPoints": 1,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:40:01.975+00",
          "seconds": 5.533,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/23",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-23",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.2,
            "w": 0.85,
            "x": 0.077,
            "y": 0.0068
          },
          "kind": "list",
          "text": "Sildenafil Cream Publication Planning: Implementing a robust medical communication strategy to educate key stakeholders in women’s health and sexual health on key aspects of FSAD/FSIAD, including pathophysiology and quality of life issues.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:01.975+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "07142389-1dec-4076-9ff0-d3d40593e740",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.85,
            "x": 0.077,
            "y": 0.0018
          },
          "kind": "list",
          "text": "XACIATO Launch: Organon, our global commercial collaborator, believes there is roughly a 90% overlap of healthcare providers who prescribe their contraceptive product NEXPLANON and have the potential to be prescribers of XACIATO. Organon and Daré are working towards a U.S. launch as soon as feasible.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:01.975+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0d863d75-2892-491b-8f3f-ad5752249bd0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.85,
            "x": 0.077,
            "y": 0.004200000000000001
          },
          "kind": "list",
          "text": "Ovaprene Commercial Readiness Activities: Organized a cross-functional team to align and activate on key aspects of the brand including packaging, messaging and KOL targeting. Activities will help set the foundation for additional down-stream, post approval sales and marketing activities.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:01.975+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "65dbbe71-83cd-4ff6-8ecf-cb9bc2132150",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.37,
            "x": 0.077,
            "y": 0.045
          },
          "kind": "title",
          "text": "Commercial Planning",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:01.975+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "beae7efb-a60f-4384-9888-9aa2e6304b7e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 24,
      "type": "setup",
      "function": "transition",
      "rawType": "section_divider",
      "block": null,
      "metadata": {
        "slideType": "section_divider",
        "slideTypeCanon": {
          "name": "Section divider",
          "slug": "section_divider",
          "status": "active",
          "canonId": "019de52d-066a-7402-9554-6ae504999041",
          "version": 1,
          "description": null
        },
        "function": "transition",
        "functionCanon": {
          "name": "Transition",
          "slug": "transition",
          "status": "active",
          "canonId": "019de52d-1365-7149-92aa-66df859e75fd",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 2,
        "componentCount": 1,
        "textChars": 19,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:58.253+00",
          "seconds": 1.64,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/24",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-24",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.178,
            "w": 0.448,
            "x": 0.276,
            "y": 0.411
          },
          "kind": "title",
          "text": "Upcoming Milestones",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:58.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2644bb60-2742-4dc6-a7cf-d31a4b9e52ae",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 25,
      "type": "resolution",
      "title": "The slide uses a bulleted list format to outline specific program milestones for five different assets.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 43,
        "componentCount": 4,
        "textChars": 489,
        "nDataPoints": 0,
        "notes": "The slide uses a bulleted list format to outline specific program milestones for five different assets.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:39:59.422+00",
          "seconds": 2.524,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/25",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-25",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.02,
            "w": 0.1,
            "x": 0.01,
            "y": 0.97
          },
          "kind": "disclaimer",
          "text": "* Anticipated timing",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.422+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "652bfa36-e36a-4089-8e57-7abcfaca2a7b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.95,
            "x": 0.02,
            "y": 0.25
          },
          "kind": "list",
          "text": "XACIATO (clindamycin phosphate) vaginal gel, 2% - First commercial sale in 2023; Ovaprene (hormone-free monthly contraception) - Pivotal Phase 3 subject enrollment to begin 4Q-2023; Sildenafil Cream, 3.6% (FSAD/FSIAD) - Activities related to psychometric analyses; DARE-PDM1 (primary dysmenorrhea) - Phase 1 study topline data 2023; IND related activities for DARE-HRT1 and DARE-VVA1",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.422+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f65969b7-0fe1-493d-9333-755704a3fe09",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.85,
            "x": 0.07,
            "y": 0.04
          },
          "kind": "title",
          "text": "Daré – Working to Accelerate Innovation in Women's Health",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.422+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9622b64b-61cf-4490-bea0-71211cfcc8e5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.3,
            "x": 0.02,
            "y": 0.17
          },
          "kind": "title",
          "text": "Upcoming Program Milestones*:",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:39:59.422+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "83168e04-beaf-44d9-871d-4f0533393497",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 26,
      "type": "setup",
      "title": "The slide uses a dual-image layout to emphasize empowerment and collaboration.",
      "function": "inspire_vision",
      "rawType": "mission",
      "block": null,
      "metadata": {
        "slideType": "mission",
        "slideTypeCanon": {
          "name": "Mission",
          "slug": "mission",
          "status": "active",
          "canonId": "019de52d-0fce-7496-b34c-18fd6a6e3310",
          "version": 1,
          "description": null
        },
        "function": "inspire_vision",
        "functionCanon": {
          "name": "Inspire vision",
          "slug": "inspire_vision",
          "status": "active",
          "canonId": "019de52d-16d0-7756-83de-376eeac6fa40",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 53,
        "componentCount": 6,
        "textChars": 360,
        "nDataPoints": 0,
        "notes": "The slide uses a dual-image layout to emphasize empowerment and collaboration.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:40:04.489+00",
          "seconds": 7.05,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de075-814d-76ed-b6e6-6e437a6b6631/26",
        "deck": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631",
        "deckAnchor": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631#slide-26",
        "deckJson": "/decks/019de075-814d-76ed-b6e6-6e437a6b6631.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.3,
            "x": 0.558,
            "y": 0.12
          },
          "kind": "callout",
          "text": "DARÉ\nIN ITALIAN, IT MEANS \"TO GIVE.\"\nIN ENGLISH, IT MEANS \"TO BE BOLD.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:04.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f9a4ddef-9fd6-491e-a7cb-a677a4ec0e79",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.06,
            "x": 0.92,
            "y": 0.18
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:04.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a69274bf-5084-4f4c-8587-0729d17958cc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.55,
            "x": 0,
            "y": 0.53
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:04.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "05a85463-de26-4960-b847-40e6d1a6914e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.49,
            "w": 0.5,
            "x": 0,
            "y": 0
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:04.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d0ec906b-2da2-4bbd-8f9a-fa0d41e0af9c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.5,
            "x": 0.47,
            "y": 0.45
          },
          "kind": "paragraph",
          "text": "At Daré Bioscience, women's health is Our Sole Focus. Innovation in women's health needs to be a priority. We are working hard to identify and advance new therapies that provide additional choices and improve outcomes so that we can make a difference in the lives of women everywhere.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:04.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9509c819-bd90-40b5-b387-a19d6029b19c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.15,
            "x": 0.47,
            "y": 0.34
          },
          "kind": "title",
          "text": "Women",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:40:04.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "323d02fe-84ef-40ec-ac41-ff6004a8b1f7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    }
  ],
  "arcBeats": [
    {
      "from": 8,
      "to": 8,
      "label": "Problem",
      "description": "The deck presents a clear problem statement on page 8"
    },
    {
      "from": 7,
      "to": 9,
      "label": "Solution",
      "description": "The deck presents solutions, including Sildenafil Cream, 3.6%, on pages 7-9"
    },
    {
      "from": 13,
      "to": 13,
      "label": "Market Size",
      "description": "The deck presents market sizing information on page 13"
    }
  ],
  "loops": [
    {
      "from": 8,
      "to": 11,
      "label": "Cost Of Inaction",
      "description": "Highlight the need for a treatment for FSAD/FSIAD"
    }
  ]
}